| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Outlook Therapeutics, Inc. (OTLK) has 10 insiders with recent SEC Form 4 filings, including 8 buys and 2 sells. OTLK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.46M | $5.46M | +24.03M | |
| CEO | 800.0K | $1.26M | - | |
| Dir | 423.7K | $669.4K | +400.0K | |
| Dir | 286.7K | $453.0K | - | |
| Dir | 117.3K | $185.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 28, 2026 | Sukhtian Ghiath M. | Director, 10% Owner | Buy | 8,539,709 | $0.59 | $4,999,999.62 | +63.0% | - | - | |
| May 26, 2026 | Thurman Randy H | Director | Buy | 5,000 | $0.43 | $2,145.00 | +843.2% | - | - | |
| May 26, 2026 | Haddadin Yezan Munther | Director | Buy | 34,000 | $0.44 | $14,960.00 | +1,074% | - | - | |
| May 26, 2026 | Hilzinger Kurt J | Director | Buy | 400,000 | $0.44 | $176,520.00 | +1,691% | - | - | |
| Sep 26, 2024 | Kenyon Lawrence A | Chief Financial Officer | Buy | 5,000 | $5.69 | $28,446.00 | +528.5% | -70.1% | -82.9% | |
| Apr 15, 2024 | Syntone Ventures LLC | 10% Owner | Buy | 714,286 | $0.00 | - | +72.1% | -2.0% | -83.9% | |
| Mar 28, 2024 | Haddadin Yezan Munther | Director | Buy | 1,882 | $11.82 | $22,241.83 | +59.4% | -40.1% | -88.9% | |
| Mar 7, 2024 | Evanson Jeff64 | Chief Commercial Officer | Buy | 62,484 | $0.42 | $26,243.28 | +8.4% | -12.5% | -81.9% | |
| Apr 20, 2023 | Dagnon Terry60 | Chief Operations Officer | Sell | 520,000 | $1.14 | $590,200.00 | -44.3% | +49.6% | -65.7% | |
| Jan 20, 2023 | Evanson Jeff64 | Chief Commercial Officer | Sell | 267,000 | $1.11 | $296,370.00 | -26.4% | +9.2% | -68.0% |